Healthcare - Biotechnology - NASDAQ - US
$ 0.211
-12.4 %
$ 3.91 M
Market Cap
-0.02
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
--13.17%
Net Income
Estimate
19.10%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Aptevo Therapeutics Inc.
APVO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart APVO
EBIT FORECAST
EBIT Forecast Chart APVO
NET INCOME FORECAST
Net Income Chart APVO